Enhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysis
From MaRDI portal
Publication:2000772
DOI10.3934/mbe.2018066zbMath1416.92091arXiv1807.04329OpenAlexW2834875999WikidataQ59351273 ScholiaQ59351273MaRDI QIDQ2000772
Rachid Ouifki, K. A. Jane White, Delfim F. M. Torres, Joseph Malinzi, Amina Eladdadi
Publication date: 28 June 2019
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1807.04329
Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15)
Related Items
Modeling the effect of vaccination and treatment on the transmission dynamics of hepatitis B virus and HIV/AIDS coinfection ⋮ Control analysis of virotherapy chaotic system ⋮ Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy ⋮ On the treatment of melanoma: a mathematical model of oncolytic virotherapy ⋮ A general non-local delay model on oncolytic virus therapy ⋮ Boundedness in a haptotactic cross-diffusion system modeling oncolytic virotherapy ⋮ Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response ⋮ Hopf bifurcation on a cancer therapy model by oncolytic virus involving the malignancy effect and therapeutic efficacy ⋮ Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: a mathematical approach ⋮ Mathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion method ⋮ Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response ⋮ Modeling the effect of contaminated objects for the transmission dynamics of COVID-19 pandemic with self protection behavior changes ⋮ Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy ⋮ Combination of virotherapy and chemotherapy with optimal control for combating cancer ⋮ A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept ⋮ Dampening effects on global boundedness in a quartic haptotactic model with fusogenic oncolytic virus and syncytia
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Stability and bifurcation analysis of delay induced tumor immune interaction model
- Lytic cycle: A defining process in oncolytic virotherapy
- Analysis of virotherapy in solid tumor invasion
- Mathematical model creation for cancer chemo-immunotherapy
- A mathematical model of vascular tumor treatment by chemotherapy
- Modeling immunotherapy of the tumor -- immune interaction
- Some mathematical models for cancer chemotherapy
- A chemotherapy model for the treatment of cancer with metastasis
- Modeling of cancer virotherapy with recombinant measles viruses
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- A model of HIV-1 infection with HAART therapy and intracellular delays
- Optimal control of the dynamics of a tumor growth model with Hollings' type-II functional response
- Modelling the spatiotemporal dynamics of chemovirotherapy cancer treatment
- A mathematical model for cell cycle-specific cancer virotherapy
This page was built for publication: Enhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysis
